the study was carried out in 45 patients ( 36 males and 9 females ) experiencing more attacks on the evaluation of an antianginal drug in a placebo-controlled trial , and to define some conditions of placebo sensitiveness in patients with angina pectoris .
C1874267
antianginal
C0002962
angina pectoris